T. Rowe Price Associates’s MetLife MET Stock Holding History

T. Rowe Price Associates’s Portfolio MET Stock Details MET Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.61B	Buy	22,787,238 +2,553,796	+13%	+$191M	0.19%	114
2025 Q4	$1.6B	Sell	20,233,442 -358,183	-2%	-$28.3M	0.17%	113
2025 Q3	$1.7B	Buy	20,591,625 +364,326	+2%	+$28.7M	0.18%	101
2025 Q2	$1.63B	Sell	20,227,299 -6,260,847	-24%	-$483M	0.18%	105
2025 Q1	$2.13B	Buy	26,488,146 +1,824,907	+7%	+$152M	0.26%	71
2024 Q4	$2.02B	Buy	24,663,239 +6,213,923	+34%	+$517M	0.23%	77
2024 Q3	$1.52B	Sell	18,449,316 -13,728,972	-43%	-$1.03B	0.18%	110
2024 Q2	$2.26B	Buy	32,178,288 +2,584,935	+9%	+$185M	0.27%	69
2024 Q1	$2.19B	Sell	29,593,353 -495,009	-2%	-$34.5M	0.27%	71
2023 Q4	$1.99B	Sell	30,088,362 -6,351,039	-17%	-$397M	0.27%	78
2023 Q3	$2.29B	Buy	36,439,401 +272,724	+0.8%	+$17M	0.34%	56
2023 Q2	$2.04B	Buy	36,166,677 +8,626,383	+31%	+$479M	0.28%	68
2023 Q1	$1.6B	Buy	27,540,294 +1,930,271	+8%	+$130M	0.24%	88
2022 Q4	$1.85B	Buy	25,610,023 +5,444,254	+27%	+$390M	0.3%	76
2022 Q3	$1.23B	Buy	20,165,769 +5,876,930	+41%	+$375M	0.2%	101
2022 Q2	$897M	Sell	14,288,839 -2,761,492	-16%	-$183M	0.11%	197
2022 Q1	$1.2B	Sell	17,050,331 -8,211,487	-33%	-$555M	0.12%	172
2021 Q4	$1.58B	Sell	25,261,818 -6,156,245	-20%	-$386M	0.14%	143
2021 Q3	$1.94B	Sell	31,418,063 -7,475,148	-19%	-$450M	0.18%	112
2021 Q2	$2.33B	Sell	38,893,211 -3,666,245	-9%	-$232M	0.22%	103
2021 Q1	$2.59B	Buy	42,559,456 +4,515,838	+12%	+$249M	0.26%	83
2020 Q4	$1.79B	Sell	38,043,618 -2,410,688	-6%	-$104M	0.18%	123
2020 Q3	$1.5B	Buy	40,454,306 +2,636,234	+7%	+$100M	0.17%	123
2020 Q2	$1.38B	Buy	37,818,072 +9,754,159	+35%	+$340M	0.17%	122
2020 Q1	$858M	Buy	28,063,913 +5,864,757	+26%	+$260M	0.14%	158
2019 Q4	$1.13B	Buy	22,199,156 +4,632,386	+26%	+$224M	0.15%	147
2019 Q3	$828M	Sell	17,566,770 -1,311,739	-7%	-$62.5M	0.12%	194
2019 Q2	$938M	Buy	18,878,509 +564,654	+3%	+$26.5M	0.13%	170
2019 Q1	$780M	Sell	18,313,855 -240,141	-1%	-$10.6M	0.11%	191
2018 Q4	$762M	Sell	18,553,996 -10,788,741	-37%	-$463M	0.13%	162
2018 Q3	$1.37B	Sell	29,342,737 -1,429,422	-5%	-$65.3M	0.2%	118
2018 Q2	$1.34B	Buy	30,772,159 +4,657,447	+18%	+$217M	0.21%	115
2018 Q1	$1.2B	Buy	26,114,712 +5,822,504	+29%	+$283M	0.19%	118
2017 Q4	$1.03B	Sell	20,292,208 -4,736,241	-19%	-$249M	0.17%	137
2017 Q3	$1.3B	Sell	25,028,449 -7,106,703	-22%	-$346M	0.22%	105
2017 Q2	$1.57B	Sell	32,135,152 -1,193,603	-4%	-$55.4M	0.28%	87
2017 Q1	$1.57B	Buy	33,328,755 +1,382,961	+4%	+$65.9M	0.29%	81
2016 Q4	$1.53B	Sell	31,945,794 -1,208,420	-4%	-$55.4M	0.3%	80
2016 Q3	$1.31B	Buy	33,154,214 +678,046	+2%	+$25.5M	0.26%	89
2016 Q2	$1.15B	Sell	32,476,168 -7,258,062	-18%	-$283M	0.24%	103
2016 Q1	$1.56B	Sell	39,734,230 -4,249,597	-10%	-$159M	0.33%	71
2015 Q4	$1.89B	Buy	43,983,827 +3,861,629	+10%	+$170M	0.4%	55
2015 Q3	$1.69B	Buy	40,122,198 +5,564,497	+16%	+$260M	0.38%	61
2015 Q2	$1.72B	Buy	34,557,701 +3,071,954	+10%	+$145M	0.35%	64
2015 Q1	$1.42B	Buy	31,485,747 +1,875,797	+6%	+$84.3M	0.29%	88
2014 Q4	$1.43B	Buy	29,609,950 +1,757,674	+6%	+$83.5M	0.3%	82
2014 Q3	$1.33B	Buy	27,852,276 +7,024,008	+34%	+$341M	0.29%	82
2014 Q2	$1.03B	Buy	20,828,268 +1,337,084	+7%	+$62.6M	0.22%	109
2014 Q1	$917M	Buy	19,491,184 +1,115,308	+6%	+$51.3M	0.21%	122
2013 Q4	$883M	Sell	18,375,876 -275,720	-1%	-$12.4M	0.2%	129
2013 Q3	$780M	Sell	18,651,596 -3,898,378	-17%	-$168M	0.19%	135
2013 Q2	$920M	Buy	+22,549,974	New	+$829M	0.25%	102

Other funds holding MET

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

T. Rowe Price Associates's MET Position: Q1 2026 in Review

T. Rowe Price Associates increased its MetLife (MET) stake by 13% in Q1 2026, buying an estimated $191M and bringing the position to 22,787,238 shares worth $1.61B. The position accounts for 0.19% of the portfolio, ranked #114.

T. Rowe Price Associates first reported a position in MET in Q2 2013 and has held it in 52 quarters since. The position peaked at $2.59B in Q1 2021. 1,371 funds tracked by Wall St. Rank hold MET as of Q1 2026.

T. Rowe Price Associates held 22,787,238 shares of MetLife worth $1.61B as of Q1 2026.
T. Rowe Price Associates bought 2,553,796 MetLife shares in Q1 2026, an estimated $191M.
MetLife made up 0.19% of T. Rowe Price Associates's portfolio in Q1 2026, its #114 holding.
T. Rowe Price Associates first reported a position in MetLife in Q2 2013 and has held it in 52 quarters since.
T. Rowe Price Associates's MetLife position peaked at $2.59B in Q1 2021.
1,371 funds tracked by Wall St. Rank held MetLife as of Q1 2026.

Based on T. Rowe Price Associates's 13F filing for Q1 2026, filed 15 May 2026.